Dorsey Wright & Associates’s Axcelis ACLS Stock Holding History

Dorsey Wright & Associates’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-396	Closed	-$11K	–	298
2020 Q2	$11K	Hold	396	–	–	﹤0.01%	215
2020 Q1	$7K	Buy	+396	New	+$9.2K	﹤0.01%	211

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dorsey Wright & Associates's ACLS Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Axcelis (ACLS) in Q3 2020, closing a stake of 396 shares — an estimated $11K sold.

Dorsey Wright & Associates first reported a position in ACLS in Q1 2020 and held it in 2 quarters. The position peaked at $11K in Q2 2020. 177 funds tracked by Wall St. Rank hold ACLS as of Q3 2020.

Dorsey Wright & Associates reported no remaining Axcelis position as of Q3 2020 after selling out during the quarter.
Dorsey Wright & Associates sold 396 Axcelis shares in Q3 2020, an estimated $11K.
Dorsey Wright & Associates first reported a position in Axcelis in Q1 2020 and held it in 2 quarters.
Dorsey Wright & Associates's Axcelis position peaked at $11K in Q2 2020.
177 funds tracked by Wall St. Rank held Axcelis as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.